-
Researchers Launch Viruses Against Mesothelioma Tumors
One of the most exciting areas of study in the fight against malignant mesothelioma is the use of viruses to fight the rare form of cancer at the cellular level. Referred to as virotherapy, the protocol involves infecting malignant cells with a virus meant to kill them: the viruses are injected directly into the tumor,
-
Judge Accuses Johnson & Johnson of “Forum Shopping,” Sides With Mesothelioma Victim
Mesothelioma victims all over the country have filed personal injury lawsuits against Johnson & Johnson, saying that the company’s iconic Baby Powder product was contaminated with asbestos and led to their fatal illness. In denying responsibility, Johnson & Johnson has acted extremely aggressively against plaintiffs. One example can be seen in the case of Dana
-
Baltimore Man’s $7.3 Million Mesothelioma Verdict Upheld by Appeals Court
In the face of unquestionable scientific proof that exposure to asbestos causes malignant mesothelioma, it would seem like common sense that companies that sold and installed asbestos-containing materials would take responsibility when confronted by those who were sickened by their actions or products. Unfortunately that is not the case, and countless victims diagnosed with asbestos-related
-
Direct Injection of CAR-T Cells Into Chest Cavity Yields Promising Results for Mesothelioma Patients
A researcher who has devoted ten years to finding the right target for cancer-fighting CAR-T cells has announced extremely positive results from a Phase 1 clinical trial focused on patients with malignant pleural mesothelioma. The study injected the treatment directly into the chest cavity of 27 patients rather than delivering the medication intravenously, and delivered
-
Study Identifies Nonexpandable Lung As Predictor of Mortality in Mesothelioma
Nonexpandable lung is a symptom that is commonly experienced by patients diagnosed with malignant mesothelioma. The condition is characterized by the patient being unable to expand their lung to the chest wall, and therefore to breathe in and out normally, and it can be caused by both inflammation and by fibrotic changes within the chest
-
Discovery of Mesothelioma-Promoting Molecule Announced by Italian Researchers
There are many different approaches being taken by scientists searching for a cure for malignant mesothelioma. While some pursue more effective uses of surgery, radiation or chemotherapy, others are looking to target mechanisms within the cell, robbing the rare form of cancer of its ability to grow and spread. This is exactly what Pierluigi Scalia,
-
Chinese Researchers Identify Three Genes With Key Role In Mesothelioma Survival
All around the world, scientists are working hard to gain a greater understanding of malignant mesothelioma, including how it develops, how it progresses, and (most importantly), how to treat it most effectively. Researchers in China led by Zunyi Medical University’s Jian-Guo Zhou recently made a discovery that may have far-reaching impact for predicting the overall
-
Fearing Mesothelioma and Other Illnesses, San Diego Firefighters Sue
Following revelations that the city of San Diego had put them at risk for mesothelioma and other asbestos-related diseases, hundreds of firefighters and other fire department employees have filed a negligence claim holding the city responsible for their potential medical damages. The issue was raised after an investigation showed that the city had known that
-
Longshoreman With Mesothelioma Wins Fight for Medical Expenses
Jerry Craft’s long battle with the companies that caused his malignant mesothelioma has finally been resolved after an appeals court ruled in his favor and granted him the funds for his future medical expenses. The 84-year-old Craft was first diagnosed with the rare and fatal form of cancer in 2017 after a long career as
-
BDNF Protein Linked to Poor Mesothelioma Prognosis
A protein that is found in the brain and other tissues has been linked directly to malignant mesothelioma, making it easier for physicians to diagnose the condition, as well as to craft a tailored course of treatment and set expectations for patients as to their prognosis. The protein is a biomarker known as BDNF, or
-
Washington State Appeals Court Rejects Argument Against Mesothelioma Liability
Two years after a state trial court decided that a company that had purchased another was responsible for the mesothelioma caused by that company’s negligence, the purchasing company appealed their verdict. The successor company, Elementis, also tried to deny the victim’s stepdaughter the right to a portion of the damages assessed based upon the fact
-
Former Lab Tech Wins $70 Million Jury Verdict Following Mesothelioma Diagnosis
Though malignant mesothelioma is most frequently diagnosed in people who have been exposed to asbestos in with blue collar jobs such as factory work, construction work, boiler repairmen, electricians and plumbers, the truth is that exposure to asbestos in any setting poses a very real danger. This became painfully clear during a two-week trial in
-
Conrail Loses Asbestos-Related Lung Cancer Case Against Ex-Smoker
The scientific community has determined that exposure to asbestos dramatically increases the risk that cigarette smokers will be diagnosed with malignant mesothelioma, and the same is true of lung cancer. Yet despite incontrovertible evidence in support of this connection, Consolidated Rail Corporation (Conrail) argued in court against its responsibility for a longtime railroad worker’s diagnosis
-
Study Shows That Music May Reduce Pain for Mesothelioma Patients
We’ve all heard that “music soothes the savage beast,” but is there a chance that it can also reduce the suffering endured by mesothelioma patients and others diagnosed with cancer? Thats what researchers in Taiwan have concluded after a groundbreaking study. Scientists from Taipei Medical University found that cancer patients who had been instructed to
-
FDA Approves First New Mesothelioma Treatment in Fifteen Years
In what is being heralded as groundbreaking news for those suffering with malignant mesothelioma, the U.S. Food and Drug Administration has given its approval of a new treatment called the NovoTTF-100L System specifically for the treatment of the rare and deadly form of cancer: it’s the first such approval to be granted for a mesothelioma
-
Jury Orders J & J to Pay $25 Million to Woman With Malignant Mesothelioma
A New York jury has awarded $25 million in compensatory damages to a 66-year-old woman who blames their talc-based baby powder product for her malignant mesothelioma. Donna Olson and her husband Robert filed their lawsuit in 2017, indicating that she had used both Johnson & Johnson’s Baby Powder and their scented Shower to Shower product
-
District Court Upholds $33 Million Award for Mesothelioma Widow
Ann Finch lost her husband Franklin to malignant mesothelioma in January of 2017, just months after he had been diagnosed with the rare and fatal form of cancer. In October a North Carolina federal jury awarded her $32.7 million in damages, assigning blame to Covil Corporation, a pipe insulation company that had sold all of
-
Immigrant’s Dream of a Better Life Ended By Malignant Mesothelioma
An immigrant’s dream of a better life in America came to a tragic end in 2016 when he died following a nearly two-year battle with malignant mesothelioma. Before Branko Srica succumbed to his disease, he provided testimony about exposure to asbestos that occurred over 11 years of removing and replacing asbestos tiles as part of
-
Experts Work to Close Care Gap for Mesothelioma and Other Cancers in Rural Areas
Patients who are diagnosed with malignant mesothelioma face significant challenges, and only state-of-the-art treatment can help them. Unfortunately, for those who work in rural areas, that treatment is not readily available. Addressing that very real problem was the topic of recent meeting led by the chief executive officer of the American Society of Clinical Oncology.
-
Baltimore Event Highlights Impact of Clinical Trials for Mesothelioma and Other Illnesses
Before being diagnosed with malignant mesothelioma, Raya Bodnarchuk was already being celebrated as a noted artist and sculptor who taught at the Corcoran School of Art in Washington, D.C. But most recently she was recognized for an entirely different reason: she and several other participants in clinical trials were invited to speak about their positive
